The substances with a chemical moiety are derived from plants known as phytochemicals. The detailed study of thesephytochemicals is called asphytochemistrywhich describes the structures of large number ofsecondary metaboliccompounds which are observed in plants. It consists of wide range of organic substances that are accumulated by plants and which further deals with the chemical structures, biosynthesis, metabolism, distribution and biological function of the substances.
Herbal drugs were standardised based on the chemical and biological activity profile is an important prerequisite for acquiring the herbal market. The global market for botanical and plant-derived drugs was valued at $24.4 billion in 2014. This broad market is expected to reach approx. $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020.